Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.35 |
| ▸ | MAOB | P27338 | 5/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23273322 | 0.97 | MAOA (0.38) | MAOAMAOBGRIN2BLMNAKDM4E | |
| SCHEMBL28804535 | 0.95 | MAOA (0.37) | MAOAMAOBGRIN2BDRD2DRD3 | |
| SCHEMBL28762178 | 0.86 | PARP11 (0.36) | MAOAMAOBCDC25BTSHRLIPG | |
| SCHEMBL22982711 | 0.83 | NPC1 (0.35) | MAOAMAOBCDC25BKDM4ENPC1 | |
| SCHEMBL23273337 | 0.82 | ALDH1A1 (0.34) | MAOAMAOBLMNAKDM4EGLA | |
| SCHEMBL28804530 | 0.81 | NPC1 (0.35) | MAOAMAOBCDC25BNPC1RAB9A | |
| SCHEMBL28804636 | 0.81 | ALDH1A1 (0.33) | MAOAMAOBLMNAKDM4EGLA | |
| SCHEMBL22982484 | 0.79 | — | — | |
| SCHEMBL28804741 | 0.77 | — | — | |
| SCHEMBL22982469 | 0.77 | KCNH2 (0.37) | MAOAMAOBKDM4ENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11661465-B2 | Dimer selective metallocene catalysts, non-aromatic hydrocarbon soluble activators, and processes to produce poly alpha-olefin oligmers therewith | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-05-30 | — | — | US | disclosed |
| CN-114845980-A | Dimer-selective metallocene catalyst, non-aromatic hydrocarbon soluble activator and method for preparing poly alpha-olefin oligomer using the same | 埃克森美孚化学专利公司 | 2022-08-02 | — | — | CN | disclosed |
| EP-4010385-A1 | PROCESS TO PRODUCE LOW VISCOSITY POLYALPHAOLEFINS USING NON-AROMATIC-HYDROCARBON SOLUBLE ACTIVATORS | ExxonMobil Chemical Patents Inc. (US) | 2022-06-15 | — | — | EP | disclosed |
| CN-114502521-A | Process for producing low viscosity polyalphaolefins using non-aromatic hydrocarbon soluble activators | 埃克森美孚化学专利公司 | 2022-05-13 | — | — | CN | disclosed |
| WO-2021086926-A1 | DIMER SELECTIVE METALLOCENE CATALYSTS, NON-AROMATIC HYDROCARBON SOLUBLE ACTIVATORS, AND PROCESSES TO PRODUCE POLY ALPHA-OLEFIN OLIGMERS THEREWITH | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-05-06 | — | — | WO | disclosed |
| US-20210122859-A1 | Dimer Selective Metallocene Catalysts, Non-Aromatic Hydrocarbon Soluble Activators, And Processes To Produce Poly Alpha-Olefin Oligmers Therewith | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2021-04-29 | — | — | US | disclosed |
| WO-2021030045-A1 | PROCESS TO PRODUCE LOW VISCOSITY POLYALPHAOLEFINS USING NON-AROMATIC-HYDROCARBON SOLUBLE ACTIVATORS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11661465-B2 | Dimer selective metallocene catalysts, non-aromatic hydrocarbon soluble activators, and processes to produce poly alpha-olefin oligmers therewith | NONO, TPR, ZNF787 | MAOA 201/4885MAOB 639/4885CDC25B 4125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.